Drug Shortage Report for GLN-ATOVAQUONE

Last updated on 2024-10-17 History
Report ID 236216
Drug Identification Number 02528495
Brand name GLN-ATOVAQUONE
Common or Proper name Mepron
Company Name GLENMARK PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) ATOVAQUONE
Strength(s) 750MG
Dosage form(s) SUSPENSION
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 210 ml Bottle
ATC code P01AX
ATC description AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2024-08-29
Actual start date 2024-08-29
Estimated end date 2024-10-09
Actual end date 2024-10-16
Shortage status Resolved
Updated date 2024-10-17
Company comments RESOLVED
Health Canada comments
Tier 3 Status No
Contact Address 1600 STEELES AVE. W., SUITE 407
CONCORD, ONTARIO
CANADA L4K 4M2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-10-17 English Compare
v11 2024-10-16 French Compare
v10 2024-10-16 English Compare
v9 2024-09-27 French Compare
v8 2024-09-27 English Compare
v7 2024-09-27 French Compare
v6 2024-09-27 English Compare
v5 2024-09-26 French Compare
v4 2024-09-26 English Compare
v3 2024-08-30 English Compare
v2 2024-08-29 French Compare
v1 2024-08-29 English Compare

Showing 1 to 12 of 12